These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 3178241

  • 1. [Pharmacokinetics of N4-behenoyl-1-beta-D-arabinofuranosylcytosine after intraperitoneal administration].
    Noda T, Oku M, Kiyozuka Y, Maruyama M, Adachi S, Akada S, Okamura Y, Ichijo M.
    Gan To Kagaku Ryoho; 1988 Oct; 15(10):2929-35. PubMed ID: 3178241
    [Abstract] [Full Text] [Related]

  • 2. Cytotoxicity of N4-behenoyl-1-beta-D-arabinofuranosylcytosine through gradual conversion to 1-beta-D-arabinofuranosylcytosine in HeLa cells.
    Maehara Y, Kusumoto T, Sakaguchi Y, Kusumoto H, Anai H, Sugimachi K.
    Anticancer Res; 1989 Oct; 9(1):41-4. PubMed ID: 2705754
    [Abstract] [Full Text] [Related]

  • 3. Effects of N4-behenoyl-1-beta-D-arabinofuranosylcytosine on blast progenitors of acute myeloblastic leukemia.
    Nara N, Tohda S, Suzuki T, Nagata K, Yamashita Y, Imai Y, Maruyama Y, Tomiyama J.
    Cancer Res; 1990 Dec 01; 50(23):7587-92. PubMed ID: 2253209
    [Abstract] [Full Text] [Related]

  • 4. [Pharmacokinetic studies of N4-behenoyl-1-beta-D-arabinofuranosylcytosine (BH-AC) by 30-minute infusion with acute nonlymphocytic leukemia--the possibility of administration for outpatients].
    Hirosawa S.
    Gan To Kagaku Ryoho; 1988 Jun 01; 15(6):1991-3. PubMed ID: 3164182
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of N4-behenoyl-1-beta-D-arabinofuranosylcytosine in patients with acute leukemia.
    Ueda T, Nakamura T, Ando S, Kagawa D, Sasada M, Uchino H, Johno I, Akiyama Y.
    Cancer Res; 1983 Jul 01; 43(7):3412-6. PubMed ID: 6850647
    [Abstract] [Full Text] [Related]

  • 6. [Clinical and pharmacokinetic studies of high dose N4-behenoyl-1-beta-D-arabinofuranosylcytosine].
    Yoshida T, Nakamura S, Ohtake S, Ito K, Kobayashi K, Kanno M, Hirai J, Tachimori K, Matsuda T.
    Gan To Kagaku Ryoho; 1987 Jun 01; 14(6 Pt 1):1820-4. PubMed ID: 3592717
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of malignant lymphoma with single administration of BH-AC (N4-behenoyl-1-beta-D-arabinofuranosylcytosine].
    Oguro M, Takagi T.
    Gan To Kagaku Ryoho; 1982 Mar 01; 9(3):508-15. PubMed ID: 6764108
    [Abstract] [Full Text] [Related]

  • 8. In vitro sensitivity of various human tumors to 1-beta-D-arabinofuranosylcytosine and N4-behenoyl-1-beta-D-arabinofuranosylcytosine.
    Maehara Y, Kusumoto T, Kusumoto H, Anai H, Sugimachi K.
    Chemotherapy; 1989 Mar 01; 35(3):181-6. PubMed ID: 2766858
    [Abstract] [Full Text] [Related]

  • 9. Clinical use of intermediate to high dose of N4-behenoyl-1-beta-D-arabinofuranosylcytosine in children with acute leukemia.
    Takashima Y.
    J Clin Pharmacol; 1988 Apr 01; 28(4):356-62. PubMed ID: 3164731
    [Abstract] [Full Text] [Related]

  • 10. [Antitumor effects of Behenoyl-ara-C (BH-AC) in combination with Idarubicin (IDA) in P 388 leukemic cell bearing mice].
    Watanabe A, Kuriyama H, Kiyota T.
    Gan To Kagaku Ryoho; 1996 Feb 01; 23(3):291-6. PubMed ID: 8712821
    [Abstract] [Full Text] [Related]

  • 11. Production of N4-succinyl-1-beta-D-arabinofuranosylcytosine, a novel metabolite of N4-behenoyl-1-beta-D-arabinofuranosylcytosine, in mice and its biological significance.
    Oh-ishi J, Kataoka T, Tsukagoshi S, Sakurai Y, Shibukawa M, Kobayashi H.
    Cancer Res; 1981 Jun 01; 41(6):2501-6. PubMed ID: 7237444
    [Abstract] [Full Text] [Related]

  • 12. [Intraperitoneal (i.p.) chemotherapy in the management of ovarian cancer--pharmacokinetics and methods of sequential i.p. chemotherapy].
    Noda T, Adachi S, Yamamoto T, Hirooka C, Kiyozuka Y, Adachi S, Oku M, Ichijo M.
    Gan To Kagaku Ryoho; 1990 Aug 01; 17(8 Pt 2):1561-8. PubMed ID: 2389949
    [Abstract] [Full Text] [Related]

  • 13. [Treatment of hypoplastic leukemia--clinical effects of low-dose 4N-behenoyl-beta-D-arabinofuranosylcytosine (BH-AC) therapy].
    Nakada H, Takahashi I, Yorimitu S, Hara M, Ohmoto E, Inagaki T, Aoyama S, Nishimura M, Hayashi N, Sekito N.
    Rinsho Ketsueki; 1987 Apr 01; 28(4):534-40. PubMed ID: 3476764
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacologic and clinical studies of N4-behenoyl-1-beta-D-arabinofuranosylcytosine.
    Yamada K, Kawashima K, Kato Y, Morishima Y, Tanimoto M, Ohno R.
    Recent Results Cancer Res; 1980 Apr 01; 70():219-29. PubMed ID: 6766563
    [Abstract] [Full Text] [Related]

  • 15. [Experimental study on the correlation between the antitumor activity and pharmacokinetics of cytosine arabinoside (Ara-C) and N4-behenoyl-1-beta-D-arabinofuranosylcytosine (BH-AC)].
    Takenaka T, Kimura K.
    Nihon Gan Chiryo Gakkai Shi; 1985 Dec 20; 20(10):2322-8. PubMed ID: 3831176
    [No Abstract] [Full Text] [Related]

  • 16. [Intraperitoneal high-dose cisplatinum chemotherapy (CDDP-ip) in patients with carcinomatous peritonitis].
    Noda T, Oku M, Kiyozuka Y, Ninomiya Y, Hino K, Okamura Y, Maruyama M, Ichijo M.
    Gan To Kagaku Ryoho; 1987 Apr 20; 14(4):1025-32. PubMed ID: 3566301
    [Abstract] [Full Text] [Related]

  • 17. Antiviral effect of antileukemic drugs N4-behenoyl-1-beta-D-arabinofuranosylcytosine (BH-AC) and 2,2'-anhydro-1-beta-D-arabinofuranosylcytosine (cyclo-C) against human cytomegalovirus.
    Nakamura K, Eizuru Y, Kumura K, Minamishima Y.
    J Med Virol; 1990 Jun 20; 31(2):141-7. PubMed ID: 1696958
    [Abstract] [Full Text] [Related]

  • 18. [Low-dose 4N-behenoyl-1-beta-D-arabinofuranosylcytosine (BHAC) in the treatment of atypical leukemia].
    Takahashi I, Nakada H, Hayashi N, Sekito N, Inagaki T, Aoyama S, Nonaka K, Ohmoto E, Kobayashi Y, Uchida K.
    Gan To Kagaku Ryoho; 1986 Sep 20; 13(9):2780-5. PubMed ID: 3463249
    [Abstract] [Full Text] [Related]

  • 19. [Pharmacokinetics following intraperitoneal infusion of cisplatinum with and without sodium thiosulfate rescue in carcinomatous peritonitis in advanced gastric cancers].
    Namatame K, Kou Y, Nakayoshi A.
    Gan To Kagaku Ryoho; 1991 Aug 20; 18(11):1784-9. PubMed ID: 1877818
    [Abstract] [Full Text] [Related]

  • 20. Antitumor effects and pharmacology of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in mice.
    Hori K, Tsuruo T, Naganuma K, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1984 Jan 20; 44(1):172-7. PubMed ID: 6690034
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.